{"slideshow_credits": null, "snippet": "Mr. Shkreli was charged with fraud this week related to activities at a hedge fund he ran and at an earlier pharmaceutical company.", "abstract": "Turing Pharmaceuticals says Martin Shkreli has resigned as chief executive after his arrest on securities fraud charges; Ron Tilles will be interim chief executive and remain chairman.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": "Stephanie Clifford contributed reporting."}, "web_url": "http://www.nytimes.com/2015/12/19/business/martin-shkreli-resigns-turing-drug-company.html", "lead_paragraph": "Mr. Shkreli was charged with fraud this week related to activities at a hedge fund he ran and at an earlier pharmaceutical company.", "headline": {"main": "Martin Shkreli Resigns From Turing Pharmaceuticals", "print_headline": "Chief of Turing Pharmaceuticals Resigns After Arrest"}, "_id": "5674483a38f0d805d002ea1d", "word_count": "1053", "multimedia": [{"height": 126, "url": "images/2015/12/19/business/19turingweb1/19turingweb1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/12/19/business/19turingweb1/19turingweb1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2015/12/19/business/19turingweb1/19turingweb1-articleLarge.jpg", "legacy": {"xlarge": "images/2015/12/19/business/19turingweb1/19turingweb1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/12/19/business/19turingweb1/19turingweb1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/12/19/business/19turingweb1/19turingweb1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-12-19T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Turing Pharmaceuticals AG", "is_major": "Y", "rank": "1"}, {"name": "persons", "value": "Shkreli, Martin (1983- )", "is_major": "Y", "rank": "2"}, {"name": "persons", "value": "Tilles, Ron (1958- )", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Securities and Commodities Violations", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Appointments and Executive Changes", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "6"}, {"name": "organizations", "value": "Retrophin Inc", "is_major": "N", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}